Investment RisksInvestment risks include potential failure of SRT systems to achieve commercial success due to reimbursement, penetration rate, and competition.
Market CompetitionSkinCure announced it would be exhibiting a fourth-generation SRT device that would compete with Sensus SRT-100 Vision image-guided SRT offering.
Revenue EstimatesDespite positive momentum, the company is lowering its revenue estimates and 12-month price target due to a slower expected revenue ramp with the inclusion of the Fair Deal Agreement model.